Business
Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts
Click here to register for Jaguar's March 27 virtual presentation at the Emerging Growth Conference Click here to register for Jaguar's March 31 investor webcast Company plans to file its annual report on March 31, 2025 on Form 10-K for the year ended ...
About this update from Jaguar Health, Inc.
[{"type":"text","content":"Click here to register for Jaguar's March 27 virtual presentation at the Emerging Growth Conference","length":103,"tagName":"p"},{"type":"text","content":"Click here to register for Jaguar's March 31 investor webcast","length":65,"tagName":"p"},{"type":"text","content":"Company plans to file its annual report on March 31, 2025 on Form 10-K for the year ended December 31, 2024","length":107,"tagName":"p"},{"type":"text","content":"SAN FRANCISCO, CA / ACCESS Newswire / March 26, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday, March 27, 2025 at the Emerging Growth Conference and that the company will conduct an investor webcast on Monday, March 31, 2025 at 8:30 a.m. Eastern to review fourth-quarter 2024 financials and provide corporate updates.","length":425,"tagName":"p"},{"type":"text","content":""As announced, a number of key catalysts are expected to occur in the second quarter of 2025 - primarily associated with ongoing crofelemer development efforts for rare diseases and cancer therapy-related diarrhea - that we believe have the potential to be value-enhancing for the company," said Conte.","length":312,"tagName":"p"},{"type":"text","content":"Participation Instructions for Jaguar's Virtual Presentation at the Emerging Growth Conference","length":98,"tagName":"p"},{"type":"text","content":"When: Thursday, March 27, 2025 from 3:40 - 3:50 PM Eastern Time","length":63,"tagName":"p"},{"type":"text","content":"Where: Online (Click Here)","length":26,"tagName":"p"},{"type":"text","content":"Registration link for conference: Click Here","length":44,"tagName":"p"},{"type":"text","content":"Participation Instructions for Jaguar Investor Webcast","length":54,"tagName":"p"},{"type":"text","content":"When: Monday, March 31, 2025 at 8:30 AM Eastern Time","length":52,"tagName":"p"},{"type":"text","content":"Participant Registration & Access Link: Click Here","length":54,"tagName":"p"},{"type":"text","content":"Replay: An archived webcast will be available on the investor relations section of Jaguar's website: (click here)","length":117,"tagName":"p"},{"type":"text","content":"About the Jaguar Health Family of CompaniesJaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on d...